Giorgia Brancolini

Short Bio

CNR Senior Researcher working for a decade on multi-scale modeling of Interfaces between Biomolecules and Nanomaterials, Biological Macromolecules and Proteins Folding Dynamics, using methods ranging from ab initio calculations to atomistic and coarse grained molecular dynamics. Currently PI of a PNRR Extended 2022 Network 13, EU Grant (One Health Basic and Translational Research Actions) and PI of National Grants (PRIN2020, CNR SEED) she is co-Inventor of and Italian patent deposit “Biosensore per la rilevazione di particelle virali” (2022) PI of several supercomputing projects (e.g. Oak Ridge (USA): CNMS2020-B-00433; HPC-Europa: 2019/ HPC177BQ0O). She teaches at the Department of Physics Univ. Modena currently “Chemical Physics of Biomolecules”, Master's degree in Physics. She is the author of ~40 peer-review papers, with h factor 18 (source: scopus/scholar), and contributed to ~20 conferences with invited talks.

Research Interests

Development of Anti-SARS-Cov2 Therapeutic Strategies; Design of Biosensors; Functionalized Metal Nanoparticles as Nanotheranostic Agents; Intrinsically Disordered Proteins.

 

Selected Recent Projects

2022-2025: PI of PE13 Spoke 5 PNRR "One Health Basic and Translational Research Actions addressing Unmet Needs on Emerging Infectious Diseases" https://www.nano.cnr.it/research/fundamental-and-translational-nanobiophysics/
2021-2024: PI of RU PRIN2020 Project “Early Phase Preclinical Development of PACECOR, a Mutation-Independent Anti-SARS-Co2 Therapeutic Strategy”
2016-2018: PI of SEED CNR national project (GAE PUSEED04): “LOPE-DeveLopment of a Coarse Grained Model for Nanoparticle-Protein IntEractions.” CNR Seed’s Project. Granted Budget: 15.000 Euro. PI G. Brancolini [Development of a CG methodology to study the Nanoparticle-Protein interactions]

2020-2022: PI of Supercomputing project “Molecular strategies to inhibit the COVID-19-cell interaction” at ORNL, USA. CNMS2020-B-00433. Granted 1.000.000 CPU hours (2 years). [Developing an in silico strategy to design biological inhibitors of SARS-CoV-2]


Selected Publications